Release Date: July 31, 2025
Expiration Date: July 31, 2026
Activity Overview
Review of data presented at recent conferences on newer therapies for neovascular age-related macular degeneration and diabetic macular edema.
This online activity is designed to update clinicians on data presented at meetings of retina specialists; these include the Retina World Congress that was held from May 8 to 11, 2025, in Fort Lauderdale, Florida; the Association for Research in Vision and Ophthalmology 2025 Annual Meeting that was held from May 4 to 8, 2025, in Salt Lake City, Utah; and the MacularArt 2025 International Conference from June 29 through July 1, 2025, in Paris, France. Expert thought leaders provide insights to help clinicians apply findings to their management of patients with neurovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) when using newer therapies that support longer treatment intervals.
Target Audience
This activity is directed toward retina specialists, comprehensive ophthalmologists, optometrists, and other eye care professionals involved in the treatment of neovascular retinal disease.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Summarize emerging evidence regarding the management of nAMD
- Summarize emerging evidence regarding the management of DME
- Identify appropriate patient populations who may benefit from evidence-based therapies used in the management of retinal vein occlusion based on clinical presentation and goals of treatment
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here